Related Experiment Video
Updated: Aug 3, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis
J Twiss1, A W Stewart, C A Byrnes
1Starship Children's Hospital, Private Bag 92024, Auckland, New Zealand. jtwiss@ihug.co.nz
Insights
Children with bronchiectasis (BX) experience significant lung function decline over time. This study highlights the need for effective interventions to prevent long-term health issues in pediatric patients with BX.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Research
Background:
- Limited data exists on the progression of non-cystic fibrosis bronchiectasis (BX) in children.
- Understanding lung function changes is crucial for prognosis and treatment evaluation in pediatric BX.
- Comparison with cystic fibrosis (CF) populations can provide valuable insights.
Purpose of the Study:
- To evaluate the longitudinal changes in lung function in children with bronchiectasis.
- To identify covariates influencing lung function decline in pediatric BX.
- To compare the progression of lung function in children with BX to those with CF.
Main Methods:
- Longitudinal analysis of lung function data (FEV1) in children with BX and CF (n=44 each) over a mean of 5.7 years.
- Inclusion criteria: >=3 years of lung function data, age 6-15 years at testing, diagnosis via HRCT, sweat tests, and genetic studies.
- Comparison of analysis strategies ('best annual' vs. 'all data') and reference equations.
Main Results:
- Children with BX showed a significant decline in FEV1 (1.9% per annum) using the 'best annual' data approach.
- Post-infectious BX and chronic Haemophilus influenzae infection were associated with more severe disease.
- Children with CF had a steeper FEV1 decline (-2.9% per annum) compared to BX.
Conclusions:
- Pediatric bronchiectasis is characterized by significant, progressive airway obstruction.
- Lung function deterioration occurs irrespective of the analysis method or reference data used.
- Urgent development of effective interventions is necessary to mitigate morbidity and mortality in adult survivors of childhood BX.
Background:
Little has been published on the progression of non-cystic fibrosis bronchiectasis (BX), especially in childhood. Data are needed for prognosis and evaluation of the effectiveness of treatments. A study was undertaken to evaluate the change in lung function over time in children with BX, and to consider covariates and compare them with the local cystic fibrosis (CF) population.
Methods:
Children with BX or CF and > or =3 calendar years of lung function data were identified from hospital clinics. Diagnosis was made by high resolution CT scans, sweat tests, and genetic studies. Lung function performed on a single plethysmograph between 6 and 15 years of age and > or =6 weeks after diagnosis was analysed longitudinally (linear mixed model). The impact of reference equation and "best annual" versus "all data" approaches were evaluated.
Results:
There were 44 children in each of the BX and CF groups with an overall mean 5.7 calendar years follow up data. The estimated forced expiratory volume in 1 second (FEV(1)) in the BX group had an intercept of 68% predicted (Polgar) at 10 years of age which fell at a rate of 1.9% per annum using "best annual" data compared with 63% and 0.9% using "all data". Those with post-infectious BX or chronic Haemophilus influenzae infection had more severe disease. In CF the FEV(1) ("best annual") intercept was 85% predicted with a slope of -2.9% per annum. The choice of reference equation affected the magnitude of the result but not the conclusions.
Conclusion:
Children with BX have significant airway obstruction which deteriorates over time, regardless of analysis strategy or reference. Effective interventions are needed to prevent significant morbidity and adult mortality.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features